3. Yang AJ, Coronado RA, Hoffecker L, et al. Conservative care in lumbar spine surgery trials: a descriptive literature review. Arch Phys Med Rehabil 2017;98:165–72.
5. Amirdelfan K, Webster L, Poree L, Sukul V, McRoberts P. Treatment options for failed back surgery syndrome patients with refractory chronic pain: an evidence based approach. Spine (Phila Pa 1976) 2017;42(Suppl 14): S41–52.
7. Kepler CK, Markova DZ, Hilibrand AS, et al. Substance P stimulates production of inflammatory cytokines in human disc cells. Spine (Phila Pa 1976) 2013;38:E1291–9.
8. Koerner JD, Markova DZ, Schroeder GD, et al. The effect of substance P on an intervertebral disc rat organ culture model. Spine (Phila Pa 1976) 2016;41:1851–9.
9. Sainoh T, Orita S, Miyagi M, et al. Single intradiscal injection of the interleukin-6 receptor antibody tocilizumab provides short-term relief of discogenic low back pain; prospective comparative cohort study. J Orthop Sci 2016;21:2–6.
13. Krock E, Rosenzweig DH, Chabot-Dore AJ, et al. Painful, degenerating intervertebral discs up-regulate neurite sprouting and CGRP through nociceptive factors. J Cell Mol Med 2014;18:1213–25.
15. Brain SD, Geppetti P. Calcitonin gene-related peptide (CGRP) mechanisms: focus on migraine. Cham: Springer; 2019.
16. Mohanty D, Lippmann S. CGRP inhibitors for migraine. Innov Clin Neurosci 2020;17:39–40.
18. Orita S, Eguchi Y, Kamoda H, et al. Brain-derived neurotrophic factor inhibition at the punctured intervertebral disc downregulates the production of calcitonin gene-related peptide in dorsal root ganglia in rats. Spine (Phila Pa 1976) 2011;36:1737–43.
19. Ohtori S, Takahashi K, Chiba T, Yamagata M, Sameda H, Moriya H. Substance P and calcitonin gene-related peptide immunoreactive sensory DRG neurons innervating the lumbar intervertebral discs in rats. Ann Anat 2002;184:235–40.
20. Horii M, Orita S, Nagata M, et al. Direct application of the tumor necrosis factor-α inhibitor, etanercept, into a punctured intervertebral disc decreases calcitonin gene-related peptide expression in rat dorsal root ganglion neurons. Spine (Phila Pa 1976) 2011;36:E80–5.
22. Kepler CK, Markova DZ, Dibra F, et al. Expression and relationship of proinflammatory chemokine RANTES/CCL5 and cytokine IL-1β in painful human intervertebral discs. Spine (Phila Pa 1976) 2013;38:873–80.
26. Kivitz AJ, Gimbel JS, Bramson C, et al. Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain. Pain 2013;154:1009–21.
27. Hochberg MC, Tive LA, Abramson SB, et al. When is osteonecrosis not osteonecrosis?: adjudication of reported serious adverse joint events in the tanezumab clinical development program. Arthritis Rheumatol 2016;68:382–91.